ZNF517
gene geneOn this page
Summary
ZNF517 (zinc finger protein 517, HGNC:27984) is a protein-coding gene on chromosome 8q24.3, encoding Zinc finger protein 517 (Q6ZMY9). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 340385 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 114 total
- MANE Select transcript:
NM_213605
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27984 |
| Approved symbol | ZNF517 |
| Name | zinc finger protein 517 |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000197363 |
| Ensembl biotype | protein_coding |
| Entrez | 340385 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000359971, ENST00000525105, ENST00000526178, ENST00000528012, ENST00000529429, ENST00000530879, ENST00000533965, ENST00000903326, ENST00000903327
RefSeq mRNA: 7 — MANE Select: NM_213605
NM_001317936, NM_001384904, NM_001384905, NM_001384906, NM_001384907, NM_001384908, NM_213605
CCDS: CCDS6434, CCDS94367
Canonical transcript exons
ENST00000359971 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001413398 | 144807191 | 144810084 |
| ENSE00001422286 | 144803641 | 144803767 |
| ENSE00003487853 | 144804125 | 144804238 |
| ENSE00003505352 | 144802870 | 144802947 |
| ENSE00003917455 | 144798913 | 144798937 |
Expression profiles
Bgee: expression breadth ubiquitous, 158 present calls, max score 84.26.
FANTOM5 (CAGE): breadth broad, TPM avg 0.4943 / max 15.8044, expressed in 256 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 91536 | 0.4943 | 256 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 84.26 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 82.63 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.33 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.17 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.80 | gold quality |
| left ovary | UBERON:0002119 | 81.64 | gold quality |
| right ovary | UBERON:0002118 | 81.26 | gold quality |
| body of uterus | UBERON:0009853 | 81.15 | gold quality |
| right adrenal gland | UBERON:0001233 | 81.12 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.97 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.94 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 80.94 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 80.75 | gold quality |
| apex of heart | UBERON:0002098 | 80.74 | gold quality |
| gastrocnemius | UBERON:0001388 | 80.67 | gold quality |
| left adrenal gland | UBERON:0001234 | 80.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 80.50 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 80.45 | gold quality |
| muscle of leg | UBERON:0001383 | 80.22 | gold quality |
| prefrontal cortex | UBERON:0000451 | 80.15 | gold quality |
| ventricular zone | UBERON:0003053 | 80.01 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 79.94 | gold quality |
| left uterine tube | UBERON:0001303 | 79.62 | gold quality |
| cerebellum | UBERON:0002037 | 79.40 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 79.37 | gold quality |
| lower esophagus | UBERON:0013473 | 79.36 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.34 | gold quality |
| adenohypophysis | UBERON:0002196 | 79.31 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 79.31 | gold quality |
| mucosa of stomach | UBERON:0001199 | 79.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting ZNF517, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-5000-3P | 98.79 | 65.63 | 1251 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-4436A | 98.05 | 64.83 | 1140 |
| HSA-MIR-3674 | 97.01 | 68.86 | 1171 |
| HSA-MIR-3690 | 96.44 | 65.18 | 737 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 517 — Q6ZMY9 (reviewed: Q6ZMY9)
All UniProt accessions (4): E9PIL1, Q6ZMY9, G3V191, H0YCN3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (7): NP_001304865, NP_001371833, NP_001371834, NP_001371835, NP_001371836, NP_001371837, NP_998770* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352
UniProt features (19 total): zinc finger region 10, region of interest 2, compositionally biased region 2, sequence conflict 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZMY9-F1 | 68.77 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 20 (showing top):
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chr8q24, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CHAF1B_TARGET_GENES, PAX7_TARGET_GENES, RBM34_TARGET_GENES, UBN1_TARGET_GENES, ZNF423_TARGET_GENES, DESCARTES_MAIN_FETAL_CLC_IL5RA_POSITIVE_CELLS, ZBED5_TARGET_GENES, ZNF579_TARGET_GENES, ADA2_TARGET_GENES, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
418 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF517 | Q8N1N5 | Q8N1N5 | 580 |
| ZNF517 | COMMD5 | Q9GZQ3 | 530 |
| ZNF517 | ZNF385B | Q569K4 | 511 |
| ZNF517 | ZNF292 | O60281 | 461 |
| ZNF517 | TSHZ3 | Q63HK5 | 452 |
| ZNF517 | ZFPM1 | Q8IX07 | 359 |
| ZNF517 | LRIG1 | Q96JA1 | 348 |
| ZNF517 | DGKZ | Q13574 | 348 |
| ZNF517 | MPV17L2 | Q567V2 | 348 |
| ZNF517 | TTK | P33981 | 330 |
| ZNF517 | POGZ | Q7Z3K3 | 322 |
| ZNF517 | MRFAP1L2 | B2RBV5 | 322 |
| ZNF517 | ZBTB21 | Q9ULJ3 | 310 |
| ZNF517 | SYAP1 | Q96A49 | 303 |
| ZNF517 | KLHDC3 | Q9BQ90 | 296 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF517 | GGPS1 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (46): NUDT12 (Affinity Capture-MS), NPHP3 (Affinity Capture-MS), MICAL1 (Affinity Capture-MS), LRP1B (Affinity Capture-MS), NDUFAF7 (Affinity Capture-MS), IPP (Affinity Capture-MS), ERBB2IP (Affinity Capture-MS), SORL1 (Affinity Capture-MS), PPP2R5E (Affinity Capture-MS), PPP2CA (Affinity Capture-MS), RNF41 (Affinity Capture-MS), GNB2 (Affinity Capture-MS), ACTBL2 (Affinity Capture-MS), EFR3A (Affinity Capture-MS), TRIM28 (Affinity Capture-MS)
ESM2 similar proteins: A2CE44, A6NFI3, A6NM28, A8K8V0, O15370, O70218, O95201, P0CJ78, P10075, P10754, P28698, P70338, Q04890, Q07120, Q14V87, Q19A40, Q569E7, Q58DK7, Q5DWN0, Q5FWU5, Q5RJR4, Q5T619, Q5TEC3, Q6DD87, Q6IQX8, Q6PD29, Q6PGE4, Q6ZMY9, Q7Z7K2, Q80VM4, Q8BIF9, Q8JZL0, Q8N8E2, Q8NAF0, Q8NCA9, Q8TD94, Q8WUU4, Q96C55, Q96H86, Q96MX3
Diamond homologs: A0JPL0, A1L1L7, A2A761, A2VDP4, A3KN36, A6QLU5, A6QPT6, A7MBI1, A8MT65, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, O95780, P10076, P17014, P17023, P17025, P17030, P17032, P17098, P51523, P51814, P52736, P52742, P58317, Q02975, Q06730, Q06732, Q08DG8, Q0VCB0, Q13360, Q14584, Q14587, Q14590, Q147U1, Q16587, Q29RZ4, Q2M218
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
114 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 106 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1149 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:144798936:GG:G | donor_gain | 1.0000 |
| 8:144798937:GG:G | donor_gain | 1.0000 |
| 8:144804236:CAGGT:C | donor_loss | 1.0000 |
| 8:144804239:G:A | donor_loss | 1.0000 |
| 8:144804240:T:A | donor_loss | 1.0000 |
| 8:144798934:CAGGG:C | donor_loss | 0.9900 |
| 8:144798936:GGGTG:G | donor_loss | 0.9900 |
| 8:144798938:G:GG | donor_gain | 0.9900 |
| 8:144798939:T:A | donor_loss | 0.9900 |
| 8:144802868:A:AG | acceptor_gain | 0.9900 |
| 8:144802869:G:GG | acceptor_gain | 0.9900 |
| 8:144803589:T:A | acceptor_gain | 0.9900 |
| 8:144803590:G:A | acceptor_gain | 0.9900 |
| 8:144803764:CTAG:C | donor_loss | 0.9900 |
| 8:144803766:AGGT:A | donor_loss | 0.9900 |
| 8:144803767:GG:G | donor_loss | 0.9900 |
| 8:144803768:G:GA | donor_loss | 0.9900 |
| 8:144803769:T:G | donor_loss | 0.9900 |
| 8:144804116:T:A | acceptor_gain | 0.9900 |
| 8:144804144:A:AG | acceptor_gain | 0.9900 |
| 8:144804145:G:GG | acceptor_gain | 0.9900 |
| 8:144804237:AG:A | donor_gain | 0.9900 |
| 8:144804238:GG:G | donor_gain | 0.9900 |
| 8:144804239:G:GG | donor_gain | 0.9900 |
| 8:144804241:GAG:G | donor_loss | 0.9900 |
| 8:144807189:AGAT:A | acceptor_loss | 0.9900 |
| 8:144798934:CAGG:C | donor_gain | 0.9800 |
| 8:144798935:AGG:A | donor_gain | 0.9800 |
| 8:144798936:GGG:G | donor_gain | 0.9800 |
| 8:144802869:GA:G | acceptor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000065709 (8:144801787 T>A), RS1000100420 (8:144806074 T>C), RS1000154023 (8:144796956 C>G), RS1000164496 (8:144800981 C>T), RS1000621377 (8:144801206 C>A,T), RS1000901112 (8:144809577 C>G,T), RS1000963327 (8:144810021 C>T), RS1000970121 (8:144806138 T>G), RS1001012821 (8:144804785 C>T), RS1001028711 (8:144800895 G>A,C,T), RS1001102492 (8:144805048 T>C), RS1001192715 (8:144811108 C>A,T), RS1001353477 (8:144809778 G>A), RS1001455216 (8:144810586 G>A,C), RS1001469221 (8:144805576 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007005_3 | Logical memory (immediate recall) in normal cognition | 5.000000e-07 |
| GCST007005_4 | Logical memory (immediate recall) in normal cognition | 2.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| aminomethylphosphonic acid (AMPA) | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| 2,4-Dichlorophenoxyacetic Acid | decreases expression | 1 |
| Palmitic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.